Celltrion
068270.KS
#772
Rank
S$34.51 B
Marketcap
$166.66
Share price
1.34%
Change (1 day)
-5.07%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: S$34.51 Billion

As of November 2024 Celltrion has a market cap of S$34.51 Billion. This makes Celltrion the world's 772th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Marketcap Change
2024S$34.51 B-21.93%
2023S$44.21 B81.93%
2022S$24.30 B-22.46%
2021S$31.34 B-47.45%
2020S$59.65 B122.22%
2019S$26.84 B-20.88%
2018S$33.92 B-1.45%
2017S$34.42 B118.81%
2016S$15.73 B37.62%
2015S$11.43 B138.9%
2014S$4.78 B5.88%
2013S$4.51 B-14.95%
2012S$5.31 B12.37%
2011S$4.72 B6.49%
2010S$4.44 B139.85%
2009S$1.85 B60.51%
2008S$1.15 B4190.59%
2007S$26.88 M

End of Day market cap according to different sources

On Nov 20th, 2024 the market cap of Celltrion was reported to be:

S$34.09 Billion
by Yahoo Finance info icon info icon
S$34.09 Billion
by CompaniesMarketCap info icon info icon